Journal Article

Safety, tolerability, and efficacy of intracranial delivery of autologous iPSC-derived dopaminergic precursors in moderate to advanced Parkinson’s Disease

  • Fraint A
  • Larson P
  • Christine C
  • et al.
Parkinsonism & Related Disorders (2025) 134 107630
DOI: 10.1016/j.parkreldis.2025.107630
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Fraint, A., Larson, P. S., Christine, C. W., Phielipp, N. M., Houser, M., Sherman, S. J., & Wirth, E. D. (2025). Safety, tolerability, and efficacy of intracranial delivery of autologous iPSC-derived dopaminergic precursors in moderate to advanced Parkinson’s Disease. Parkinsonism & Related Disorders, 134, 107630. https://doi.org/10.1016/j.parkreldis.2025.107630

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free